Literature DB >> 6316162

The generation of human monocyte/macrophage cell lines.

Y Nagata, B Diamond, B R Bloom.   

Abstract

The development of continuous murine macrophage-like cell lines has permitted direct and somatic cell genetic approaches to a variety of functions of murine mononuclear phagocytes. However, few, if any, human cell lines exist that have the general characteristics of macrophages, although a promonocyte line, U937, has been reported which can be induced to differentiate into non-dividing cells with macrophage-like properties. Although murine macrophage-like lines have been obtained by transformation with simian virus 40 (SV40), this technique has not, in general, been useful in producing human cell lines, presumably because SV40 causes a lytic infection in human cells. We have therefore developed a method for transfecting primary human monocytes with SV40 DNA deleted in the origin of replication. Using this method, we have now, we believe for the first time, generated transformed human cell lines with macrophage characteristics. Three cell lines from three transfections of human monocytes expressed macrophage enzymes, phagocytic function, surface receptors including HLA-DR and DS and alloantigen presenting activity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6316162     DOI: 10.1038/306597a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  12 in total

1.  Immortalization of human fibroblasts transformed by origin-defective simian virus 40.

Authors:  D S Neufeld; S Ripley; A Henderson; H L Ozer
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

2.  Isolation and transduction of monocytes: promising vehicles for therapeutic arteriogenesis.

Authors:  Joerg Herold; Harald Tillmanns; Zhou Xing; Ruth H Strasser; Ruediger C Braun-Dullaeus
Journal:  Langenbecks Arch Surg       Date:  2006-03-25       Impact factor: 3.445

3.  Cloning of human thymic subcapsular cortex epithelial cells with T-lymphocyte binding sites and hemopoietic growth factor activity.

Authors:  S Mizutani; S M Watt; D Robertson; S Hussein; L E Healy; A J Furley; M F Greaves
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

4.  Establishment of human fibroblast cell lines with lysosomal enzyme deficiency by transformation with origin-minus SV40 DNA.

Authors:  T Furuya; T Momoi; Y Suzuki; H Sato; N Yamaguchi
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

5.  Regulation of interleukin-1 synthesis by histamine produced by mouse peritoneal macrophages per se.

Authors:  H Okamoto; K Nakano
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

6.  Extended life span of human endometrial stromal cells transfected with cloned origin-defective, temperature-sensitive simian virus 40.

Authors:  C A Rinehart; J S Haskill; J S Morris; T D Butler; D G Kaufman
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants.

Authors:  K Van Doren; Y Gluzman
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

8.  Establishment of immortalized cell lines from mouse peritoneal macrophages following transformation with SV40 early region DNA deleted at the origin of replication.

Authors:  U Kreuzburg-Duffy; C Macdonald
Journal:  Immunology       Date:  1991-03       Impact factor: 7.397

9.  Characterization of an equine macrophage cell line: application to studies of EIAV infection.

Authors:  Isabel Fidalgo-Carvalho; Jodi K Craigo; Shannon Barnes; Carolina Costa-Ramos; Ronald C Montelaro
Journal:  Vet Microbiol       Date:  2008-11-01       Impact factor: 3.293

10.  D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells.

Authors:  Lingjun Zhang; Mia D Sorensen; Bjarne W Kristensen; Guido Reifenberger; Thomas M McIntyre; Feng Lin
Journal:  Clin Cancer Res       Date:  2018-07-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.